Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
President Trump pumped the brakes last week on a pledge to shut down an import tax exemption for cheap consumer goods from ...
Equities researchers at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Onto ...
Cantor Fitzgerald started coverage on shares of Science Applications International (NYSE:SAIC – Free Report) in a research ...
Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...
ORIC Pharmaceuticals Inc. (NASDAQ: ORIC) shares rose 12% following a recommendation from Cantor Fitzgerald to buy shares amid a possible leak of encouraging clinical trial data. Analyst Prakhar ...
12h
Cryptopolitan on MSNWall Street banks are plotting crypto expansions in efforts to win Trump overWall Street’s biggest banks are wasting no time. They’ve smelled opportunity, and it reeks of Bitcoin. With newly-elected president Donald Trump embracing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results